z-logo
open-access-imgOpen Access
IMI – Industry Guidelines and Ethical Considerations for Myopia Control Report
Author(s) -
Lyndon Jones,
Björn Drobe,
José Manuel GonzálezMéijome,
Lyle S. Gray,
Timo Kratzer,
Steve Newman,
Jason J. Nichols,
Arne Ohlendorf,
Stephanie Ramdass,
Jacinto SantodomingoRubido,
Katrina L. Schmid,
Donald Tan,
Kah-Ooi Tan,
Fuensanta A. VeraDíaz,
Yee-Ling Wong,
Kate Gifford,
Serge Resnikoff
Publication year - 2019
Publication title -
investigative ophthalmology and visual science
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.935
H-Index - 218
eISSN - 1552-5783
pISSN - 0146-0404
DOI - 10.1167/iovs.18-25963
Subject(s) - ethical issues , medical prescription , variety (cybernetics) , control (management) , ethical responsibility , eye care , engineering ethics , best practice , public relations , medicine , business , medical education , political science , nursing , engineering , management , optometry , artificial intelligence , computer science , law , economics
To discuss guidelines and ethical considerations associated with the development and prescription of treatments intended for myopia control (MC).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom